CN1272105A - 含六元环的化合物,其制备方法及其作为药物的用途 - Google Patents

含六元环的化合物,其制备方法及其作为药物的用途 Download PDF

Info

Publication number
CN1272105A
CN1272105A CN98809320A CN98809320A CN1272105A CN 1272105 A CN1272105 A CN 1272105A CN 98809320 A CN98809320 A CN 98809320A CN 98809320 A CN98809320 A CN 98809320A CN 1272105 A CN1272105 A CN 1272105A
Authority
CN
China
Prior art keywords
group
independently
compound
acid
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN98809320A
Other languages
English (en)
Chinese (zh)
Inventor
N·W·比邵夫伯格
T·C·达尔
M·J·M·黑驰考克
C·U·基姆
W·卢
刘洪涛
R·G·米尔斯
M·A·威廉姆斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gilead Sciences Inc
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of CN1272105A publication Critical patent/CN1272105A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/62—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/52—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a ring other than a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/63—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/16—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
CN98809320A 1997-09-17 1998-09-15 含六元环的化合物,其制备方法及其作为药物的用途 Pending CN1272105A (zh)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US5930897P 1997-09-17 1997-09-17
US60/059,308 1997-09-17
US93864497A 1997-09-26 1997-09-26
US6019597P 1997-09-26 1997-09-26
US60/060,195 1997-09-26
US08/938,644 1997-09-26

Publications (1)

Publication Number Publication Date
CN1272105A true CN1272105A (zh) 2000-11-01

Family

ID=27369627

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98809320A Pending CN1272105A (zh) 1997-09-17 1998-09-15 含六元环的化合物,其制备方法及其作为药物的用途

Country Status (15)

Country Link
EP (1) EP1015417A1 (enExample)
JP (1) JP2001516739A (enExample)
KR (1) KR20010024123A (enExample)
CN (1) CN1272105A (enExample)
AR (1) AR013960A1 (enExample)
AU (1) AU747702B2 (enExample)
BR (1) BR9812649A (enExample)
CA (1) CA2303323A1 (enExample)
EA (1) EA003989B1 (enExample)
ID (1) ID25516A (enExample)
IL (1) IL134691A0 (enExample)
IN (1) IN190983B (enExample)
NZ (1) NZ502988A (enExample)
TR (1) TR200000723T2 (enExample)
WO (1) WO1999014185A1 (enExample)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102659615A (zh) * 2012-05-09 2012-09-12 中国药科大学 奥司他韦衍生物、其制备方法及其医药用途
CN108047076A (zh) * 2017-12-26 2018-05-18 杭州新博思生物医药有限公司 一种奥司他韦对映异构体的制备方法
CN110194728A (zh) * 2019-06-19 2019-09-03 湖南华腾制药有限公司 磷酸奥司他韦中间体的连续化合成方法
WO2022022448A1 (zh) * 2020-07-29 2022-02-03 广州市恒诺康医药科技有限公司 神经氨酸酶抑制剂类化合物、其药物组合物及其用途
CN116375595A (zh) * 2023-03-31 2023-07-04 重庆医药高等专科学校 一种磷酸奥司他韦的制备方法及精制方法
CN116666669A (zh) * 2023-07-25 2023-08-29 四川大学 VN负载的Ir团簇及其制备方法与其在催化剂中的用途
CN117105801A (zh) * 2023-07-24 2023-11-24 四川青木制药有限公司 一种奥司他韦及其磷酸盐的制备方法及其中间体

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9813480A (pt) * 1997-12-17 2000-10-10 Biocryst Pharm Inc Compostos inibidores de neuraminidase de ciclopentano substituìdo, composição e métodos de inibição da neuraminidase do vìrus da influenza- e de tratamento de infecção por vìrus da influenza-
US6455571B1 (en) 1998-04-23 2002-09-24 Abbott Laboratories Inhibitors of neuraminidases
US6518305B1 (en) 1998-04-23 2003-02-11 Abbott Laboratories Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
ES2198244T3 (es) * 1999-06-11 2004-02-01 F. Hoffmann-La Roche Ag Procedimiento para la preparacion de inhibidor ro-64-0796 de la neuraminidasa.
US6593314B1 (en) 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
BR0010525A (pt) * 1999-10-19 2002-11-26 Abbott Lab cido 1-ciclo-hexeno-1-carboxìlico e 1-ciclo-hexeno-1carboxilatos como inibidores de neuraminidase
JP2001131144A (ja) * 1999-11-02 2001-05-15 Sagami Chem Res Center ７−アザビシクロ［４．１．０］ヘプト−３−エン−３−カルボン酸エステル類の製造方法
US6403824B2 (en) 2000-02-22 2002-06-11 Hoffmann-La Roche Inc. Process for the preparation for 4,5-diamino shikimic acid derivatives
AU2001252578A1 (en) * 2000-04-25 2001-11-07 Sankyo Company Limited Preventives for influenza
WO2002092555A1 (en) * 2001-05-11 2002-11-21 Sankyo Company, Limited Sialic acid derivatives
US7122684B2 (en) 2003-03-13 2006-10-17 Roche Colorado Corporation Process for preparing 1,2-diamino compounds
CN101351438A (zh) * 2005-12-28 2009-01-21 弗·哈夫曼-拉罗切有限公司 在合成达菲中的环氧化物中间体
US8334319B2 (en) * 2008-01-04 2012-12-18 Roche Palo Alto Llc Polymorphic forms of oseltamivir phosphate
WO2011059994A2 (en) * 2009-11-11 2011-05-19 3M Innovative Properties Company Polymeric compositions and method of making and articles thereof
DE102011117128A1 (de) 2011-10-28 2013-05-02 Christian-Albrechts-Universität Zu Kiel Verbindungen zur Therapie der Influenza
RU2469020C1 (ru) * 2011-11-08 2012-12-10 Александр Васильевич Иващенко (3r,4r,5s)-5-амино-4-ациламино-3-(1-этил-пропокси)-циклогекс-1-ен-карбоновые кислоты, их эфиры и способ применения
RU2520836C1 (ru) * 2013-02-27 2014-06-27 Александр Васильевич Иващенко (3r,4r,5s)-4-амино-5-(2,2-дифторацетиламино)-3-(1-этилпропокси)-циклогекс-1-енкарбоновая кислота и ее эфиры, способ их получения и применения
RU2633085C2 (ru) * 2014-05-20 2017-10-11 Российская Федерация, от имени которой выступает Федеральное государственное казенное учреждение "Войсковая часть 68240" Противовирусное лекарственное средство в виде капсул и способ его получения
CN105439884A (zh) * 2015-10-27 2016-03-30 沈阳药科大学 一种奥司他韦的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP249A (en) * 1990-04-24 1993-03-17 Biota Scient Management Pty Ltd Anti-viral compounds.
WO1992006691A1 (en) * 1990-10-19 1992-04-30 Biota Scientific Management Pty. Ltd. Anti-viral compounds that bind the active site of influenza neuramidase and display in vivo activity against orthomyxovirus and paramyxovirus
SI9620042A (sl) * 1995-02-27 1998-12-31 Gilead Sciences, Inc. Novi selektivni inhibitorji virusnih ali bakterijskih neuraminidaz
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
EP0920410B1 (en) * 1996-08-23 2002-03-27 Gilead Sciences, Inc. Preparation of cyclohexene carboxylate derivatives

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102659615A (zh) * 2012-05-09 2012-09-12 中国药科大学 奥司他韦衍生物、其制备方法及其医药用途
CN102659615B (zh) * 2012-05-09 2014-05-07 中国药科大学 奥司他韦衍生物、其制备方法及其医药用途
CN108047076A (zh) * 2017-12-26 2018-05-18 杭州新博思生物医药有限公司 一种奥司他韦对映异构体的制备方法
CN108047076B (zh) * 2017-12-26 2020-05-08 杭州新博思生物医药有限公司 一种奥司他韦对映异构体的制备方法
CN110194728A (zh) * 2019-06-19 2019-09-03 湖南华腾制药有限公司 磷酸奥司他韦中间体的连续化合成方法
CN110194728B (zh) * 2019-06-19 2021-04-30 湖南华腾制药有限公司 磷酸奥司他韦中间体的连续化合成方法
WO2022022448A1 (zh) * 2020-07-29 2022-02-03 广州市恒诺康医药科技有限公司 神经氨酸酶抑制剂类化合物、其药物组合物及其用途
CN116375595A (zh) * 2023-03-31 2023-07-04 重庆医药高等专科学校 一种磷酸奥司他韦的制备方法及精制方法
CN117105801A (zh) * 2023-07-24 2023-11-24 四川青木制药有限公司 一种奥司他韦及其磷酸盐的制备方法及其中间体
CN116666669A (zh) * 2023-07-25 2023-08-29 四川大学 VN负载的Ir团簇及其制备方法与其在催化剂中的用途
CN116666669B (zh) * 2023-07-25 2023-10-03 四川大学 VN负载的Ir团簇及其制备方法与其在催化剂中的用途

Also Published As

Publication number Publication date
KR20010024123A (ko) 2001-03-26
AR013960A1 (es) 2001-01-31
IL134691A0 (en) 2001-04-30
EP1015417A1 (en) 2000-07-05
IN190983B (enExample) 2003-09-06
WO1999014185A1 (en) 1999-03-25
JP2001516739A (ja) 2001-10-02
AU747702B2 (en) 2002-05-16
TR200000723T2 (tr) 2001-06-21
ID25516A (id) 2000-10-05
AU9569498A (en) 1999-04-05
BR9812649A (pt) 2000-08-22
EA200000332A1 (ru) 2000-10-30
EA003989B1 (ru) 2003-12-25
CA2303323A1 (en) 1999-03-25
NZ502988A (en) 2002-08-28

Similar Documents

Publication Publication Date Title
CN1272105A (zh) 含六元环的化合物,其制备方法及其作为药物的用途
CN1185223C (zh) 新颖化合物,其合成方法及治疗用途
CN1036849C (zh) 抗病毒化合物的制备方法
JP2003513889A (ja) ノイラミニダーゼの阻害剤
US20120178705A1 (en) Methods for preparation of glycosphingolipids and uses thereof
CN112592331B (zh) 一种奥司他韦protac化合物及其制备方法与在抗流感病毒药物中的应用
JPH089585B2 (ja) アミノ酸誘導体
CN1304447A (zh) 通过抑制木瓜蛋白酶超家族的半胱氨酸蛋白酶治疗寄生虫病
CN1438991A (zh) 作为中性内肽酶的抑制剂的环戊基－取代的戊二酰胺衍生物
US20200129458A1 (en) Compound having enhancing activity for glucagon-like peptide-1 receptor actions
JP2002521312A (ja) ノイラミニダーゼの阻害剤
CN1328546A (zh) 作为神经氨酸酶抑制剂的吡咯烷
CN1347419A (zh) 吡咯烷羰基氨基环状二硫化物
HUE035856T2 (hu) Fluor-helyettesített (3R,4R,5S)-5-guanidino-4-acilamino-3-(pentán-3-iloxi)ciklohexén-1-karbonsavak, azok észterei és azok alkalmazási módszerei
CN101172957B (zh) 新颖化合物,其合成方法及治疗用途
JPWO2008093655A1 (ja) ポリアルコール化合物および医薬
CN100338031C (zh) 新颖化合物，其合成方法及治疗用途
WO2014082592A1 (zh) 神经氨酸苷酶抑制剂的前药及其组合物和用途
CN1216050C (zh) 5,6,7－三去甲－4,8－内－间亚苯基pgi2衍生物及含有其的医药
CN1094731A (zh) 2-氨基-6，7-二羟基-4-硫杂庚酸衍生物、其制备及应用
HK1088594B (en) Novel compounds and methods for synthesis and therapy
CN1258301A (zh) 抗病毒蛋白酶抑制剂
CN116003486B (zh) 一种先导化合物、其制备方法、以及其在制备抗流感病毒药物方面的应用
CN102127041B (zh) 唾液酸类似物及其在制备抗流感病毒药物中的应用
US20230399295A1 (en) Compositions for increasing tissue regeneration and delaying or reducing granuloma formation

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication